PharmaBoardroom

Interview: Tony Cruz, Chairman and CEO, Transition Therapeutics,…

Tony Cruz of Transition Therapeutics discusses the challenges of biotech companies in Canada and his company’s unique business model that has…

Interview: Ying-Yih Wu, Minister of the Overseas Chinese Affairs…

The minister in charge of medical tourism in Taiwan speaks about the country's advantages over its Asian neighbours, and how the new era of Taiwan's…

Interview: Chung-Cheng Liu, President of Adimmune Corporation,…

The president of Adimmune Corporation discusses how the avian flu outbreak of 2006/2007 changed the course of the drug manufacturing industry in…

Interview: Peter Van Der Velden, Managing General Partner, Lumira…

The funding of Canada’s biotech industry has changed drastically in recent years. Peter Van Der Velden of Lumira Capital discusses those changes and…

VAT rates on medicine in Europe, by country, in 2013

This table shows the VAT rates applied to medicines in European countries as of 1 January 2013. (1) France: reimbursable medicines 2.1%;…

Interview: Lee-Cheng Liu, President & CEO, EirGenix, Taiwan

Dr. Liu, President and CEO of EirGenix, talks about why he sees Taiwan as the ideal market for a CDMO like Eirgenix, why he believes that despite the…

Interview: Whaijen Soo Managing, Director, Supra Integration and…

Whaijen Soo, Managing Director of Supra Integration and Incubation Center (Si2C) speaks about Taiwan’s biotech industry, emphasizing the need for…

Interview: Audrey Tseng, Deputy Chairman, Lily Wong and Andy…

Audrey Tseng, Deputy Chairman of PwC Taiwan with PwC Partners Lily Wong and Andy Chang, delve into factors behind the booming pharma and biotech…

Interview: Yu-Ray Chen, Professor of Surgery, Chang Gung Memorial…

Dr Yu-Ray Chen, Professor of Surgery at Chang Gung Memorial Hospital discusses the current state of Taiwan’s healthcare system, highlighting the…

Interview: Tom Reeves, CEO, Interface Biologics, Canada

Tom Reeves of Interface Biologics (IBI) offers his input about the company’s roadmap towards commercialization, as well as IBI’s differentiation…

Interview: Sue Paish, CEO, LifeLabs, Canada

Sue Paish, Lifelabs’ Chief Executive Officer discusses the company’s recent purchase of BC Biomedical, why the market in BC and Ontario are so…

Interview: Michael Cloutier, President, InterMune, Canada

Michael Cloutier, President of InterMune, elaborates on the challenges of navigating the Canadian healthcare system as a small pharmaceutical company,…

Tagged with